论文部分内容阅读
目的:探讨论乳酸环丙沙星氯化钠注射液与头孢哌酮钠他唑巴坦钠存在的配伍禁忌。方法:笔者将乳酸环丙沙星氯化钠注射液100ml的澄清液体与头孢哌酮类抗生素凯斯1支用生理盐水溶解的澄清液体混合。结果:混合后液体内出现乳白色浑浊,1分钟后并有小块状结晶体沉积,摇动后不消失。因条件所限,尚不能明确其变浑浊的原因。结论:用每种新药前应详细查看药物说明书,熟练掌握新药物的有关知识。一旦药物出现浑浊,沉淀,絮状物,应立即关闭调节器,更换输液管,安慰患者以消除紧张心理,通知医生做相关检查,严密观察病情,确保患者治疗安全。
OBJECTIVE: To investigate the incompatibility of ciprofloxacin lactate sodium chloride injection with cefoperazone sodium tazobactam sodium. Methods: The author will be 100ml of ciprofloxacin sodium lactate injection of clear liquid and cefoperazone Case 1 Case of a clear solution of saline dissolved liquid mixing. Results: After mixing, milky opacity appeared in the liquid, and after 1 minute, there was a small piece of crystal deposition, which did not disappear after shaking. Due to limited conditions, it is still not clear why it becomes cloudy. Conclusion: Before using each new drug should be detailed view of drug instructions, master the relevant knowledge of new drugs. Once the drug appears cloudy, sediment, flocculent, should immediately turn off the regulator, replace the infusion tube, comfort patients to eliminate tension, notify the doctor to do the relevant checks, close observation of the disease, to ensure patient safety.